A 40something woman was thought to be too young for glaucoma but more people below age 60 are being diagnosed with glaucoma ...

Glaucoma can silently damage your optic nerve, leading to irreversible vision loss. Learn the early signs, risk factors, and ...

AI could revolutionise glaucoma detection. Here’s 6 things everyone should know - Age and family history are significant risk ...

Glaucoma often progresses silently, damaging vision before you even notice a problem. Experts warn that believing common myths can delay diagnosis and increase the risk of irreversible blindness.

Investigator-sponsored study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ophthalmologyFirst ...

A headache is a common occurrence for many of us, but for Effie Iemma , it was the first sign that she had glaucoma. "I had an eye test, just my normal routine eye ...

The risk for endophthalmitis after glaucoma drainage rises for up to 5 years and is much higher than that for a device-placement surgery for detached retina, a study finds.

Glaucoma develops when fluid inside the eye doesn’t drain properly, causing pressure to build up over time and damage the ...

Statin use was associated with a higher likelihood of glaucoma in adults with hyperlipidemia, even those whose "bad" cholesterol was at optimal levels, according to a cross-sectional, population-based ...

A population study of California Medicare patients found that high air pollution levels correlated with the risk for failure of incisional glaucoma surgery.

Artelo Biosciences (NASDAQ: ARTL) has announced its entry into the ophthalmology space with a fully funded clinical study evaluating ART27.13 in glaucoma patients. The investigator-sponsored trial ...

Artelo Biosciences Inc (NASDAQ:ARTL) shares jumped 32.9% Wednesday following the company’s announcement of a study agreement with Belfast Health and Social Care Trust to evaluate its drug candidate ...